Leukaemia Trial, Recruiting (NCT06747910)

Leukaemia Trial, Recruiting NCT06747910 Sponsor: St. Jude Children's Research Hospital Condition: Leukaemia

Printed from Voxsanity (voxsanity.com.au) — NCT06747910 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Leukaemia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are enrolled in the St. Jude Lifetime Cohort (SJLIFE) program and are over 18 years old.
People whose original cancer diagnosis was acute lymphoblastic leukemia (ALL), Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma — these are specific types of blood and immune system cancers.
People who are not currently taking a type of heart medication known as beta-blockers.

Who may not be able to join:

People who are not able to speak, read, or understand English.
People who are not able to follow directions well enough to complete a specific set of tests called the Ewing battery (confirm with trial site for details on what this involves).
People who are currently experiencing acute heart failure, which may include symptoms such as sudden or worsening shortness of breath, difficulty breathing when lying down, swelling in the lower legs, or fluid buildup in the lungs.
People who are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kirsten K Ness, PhD, St. Jude Children's Research Hospital

Phone: 888-226-4343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06747910

Sponsor: St. Jude Children's Research Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Leukaemia

Trial contact: 888-226-4343

More information: https://clinicaltrials.gov/study/NCT06747910

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are enrolled in the St. Jude Lifetime Cohort (SJLIFE) program and are over 18 years old.
People whose original cancer diagnosis was acute lymphoblastic leukemia (ALL), Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma — these are specific types of blood and immune system cancers.
People who are not currently taking a type of heart medication known as beta-blockers.

Who may not be able to join:

People who are not able to speak, read, or understand English.
People who are not able to follow directions well enough to complete a specific set of tests called the Ewing battery (confirm with trial site for details on what this involves).
People who are currently experiencing acute heart failure, which may include symptoms such as sudden or worsening shortness of breath, difficulty breathing when lying down, swelling in the lower legs, or fluid buildup in the lungs.
People who are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

St. Jude Children's Research Hospital

Registry

ClinicalTrials.gov

Start date

3 February 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Heart rate variability (msec); Abbreviated Composite Autonomic Symptom Score (0-100); Ewing Score (0-5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov